@BHudsonWrites @Kelly26552573 Peer-reviewed science; During trails May-Nov 2020 AstraZeneca achieves just 10.4% efficacy due to the immune escape mutation K417n. AstraZeneca was launched upon the public just a few weeks later.. https://t.co/5QELStlDby
So far, Altmetric has seen
16840 X posts from 13386 X users, with an upper bound of 26,358,157 followers.
9,013 followers
9,013 followers
@maxsonrichards @Hypothesis 1. Where have I used AI, prove your allegation. 2. Gates Foundation Funded Study commences May 2020 on B.1.351 and AstraZeneca https://t.co/5QELStmb16 3. Your response which clearly says late 2020; https://t.co/MZ1NJrdyUT
9,013 followers
@NoNotThatOne_ @RickNas95547619 @JackieParshall @VaxxersAnti AstraZeneca 10.4% https://t.co/5QELStmb16
144 followers
@NoNotThatOne_ @JackieParshall @BarryESharp @VaxxersAnti Alright, enlighten us why this would be considered crap? The study it is taken from appears to support the claim Barry made. https://t.co/BqG7ectdX1 https://t.co/PD8GvkEWgG